Clinical Usage of the Adjuvanted Herpes Zoster Subunit Vaccine (HZ/su): Revaccination of Recipients of Live Attenuated Zoster Vaccine and Coadministration With a Seasonal Influenza Vaccine

J Infect Dis. 2017 Dec 12;216(11):1329-1333. doi: 10.1093/infdis/jix484.

Michael N Oxman^{1

2}, Ruth Harbecke^{1

3}, David M Koelle^{4

5

6

7}

¹ Department of Medicine, Division of Infectious Diseases, University of California, San Diego, La Jolla.
² Medicine Service, Infectious Diseases Section, Veterans Affairs San Diego Healthcare System, California.
³ Research Service, Veterans Affairs San Diego Healthcare System, California.
⁴ Department of Medicine, Laboratory Medicine, University of Washington.
⁵ Department of Global Health, University of Washington.
⁶ Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center.
⁷ Benaroya Research Institute, Seattle, Washington.

No abstract available

Keywords: adjuvant; glycoprotein E; influenza vaccine; re-vaccination; zoster vaccine.

Publication types